EEM News 45.09 07/29/2014 05:00:35 Emrg Mkts Index MSCI Ishares

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Emrg Mkts Index MSCI Ishares (EEM) 45.09 $EEM

iShares MSCI Emerging Markets Index Fund/United States Shares Up 11.8% Since SmarTrend's Buy Recommendation (EEM)
Comtex SmarTrend(R) - Wed Jul 23, 11:20AM CDT
SmarTrend identified an Uptrend for iShares MSCI Emerging Markets Index Fund/United States (NYSE:EEM) on March 6th, 2014 at $40.02. In approximately 5 months, iShares MSCI Emerging Markets Index Fund/United States has returned 11.84% as of today's recent price of $44.76.

Emerging Markets Outperform U.S. Equities Thanks to Latin America, China
at The Street - Wed Jul 23, 10:33AM CDT
Strong growth in China and Brazil overcome weakness in Russia.

Look for Shares of iShares MSCI Emerging Markets Index Fund/United States to Potentially Rebound after Yesterday's 1.87% Sell Off
Comtex SmarTrend(R) - Thu Jul 17, 4:06PM CDT
iShares MSCI Emerging Markets Index Fund/United States (NYSE:EEM) traded in a range yesterday that spanned from a low of $43.40 to a high of $44.08. Yesterday, the shares fell 1.9%, which took the trading range below the 3-day low of $43.99 on volume of 65.2 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.

After Crimea, Where Do Russia ETFs Go Now? - ETF News And Commentary
Zacks Equity Research - Zacks Investment Research - Thu Jul 17, 7:00AM CDT
Russia ETFs have recovered a bit since the Ukraine crisis, but are they now buys?

IShares' Expansion: Going Local, Global And Core
at Investor's Business Daily - Tue Jul 15, 3:34PM CDT
BlackRock's iShares unit, the market leader in exchange traded funds, gathered $21.4 billion in new assets in the second quarter, besting Vanguard by nearly 18%. But BlackRock (BLK) isn't taking success for granted. In June, iShares widened its...

1 Easy Way to Play Emerging Markets
Selena Maranjian, The Motley Fool - Motley Fool - Tue Jul 08, 5:15PM CDT
Source: Sasol.com. Exchange-traded funds offer a convenient way to invest in sectors or niches that interest you. If you'd like to add some emerging-market companies to your portfolio but don't have the time or expertise to hand-pick a few, the ...

Strong Foreign Inflows Put Taiwan ETFs in Focus - ETF News And Commentary
Zacks Equity Research - Zacks Investment Research - Tue Jul 08, 7:00AM CDT
These Taiwan ETFs could be in focus thanks to foreign interest in the market and strength in Taiwan Semiconductor.

Five Reasons to Change Your Outlook on Emerging Markets
at The Street - Thu Jun 19, 5:00AM CDT
Instead of lumping all emerging markets together, dig a little deeper to find the indexes and countries that can appreciate over the long haul. A quarter-to-quarter focus will only hurt your portfolio.

After Yesterday's Rally of 1.11% Shares Could Potentially Pullback
Comtex SmarTrend(R) - Wed Jun 18, 3:38PM CDT
iShares MSCI Emerging Markets Index Fund/United States (NYSE:EEM) traded in a range yesterday that spanned from a low of $43.19 to a high of $43.93. Yesterday, the shares gained 1.1%, which took the trading range above the 3-day high of $43.65 on volume of 60.9 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.

SmarTrend Watching for Potential Pullback in Shares of iShares MSCI Emerging Markets Index Fund/United States After 1.11% Gain
Comtex SmarTrend(R) - Wed Jun 18, 3:37PM CDT
iShares MSCI Emerging Markets Index Fund/United States (NYSE:EEM) traded in a range yesterday that spanned from a low of $43.19 to a high of $43.93. Yesterday, the shares gained 1.1%, which took the trading range above the 3-day high of $43.65 on volume of 60.9 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.

Emerging Market ETFs in Focus on MSCI Index Review - ETF News And Commentary
Zacks Equity Research - Zacks Investment Research - Wed Jun 18, 7:00AM CDT
How emerging market ETFs might be impacted by the latest MSCI index decisions.

'Fast Money' Recap: Opening the Oil Spigot?
at The Street - Tue Jun 17, 4:00AM CDT
The trading panel discussed whether the U.S. should release some of its oil reserves and which stocks to buy if it does.

EEM, BAP, MBT, SCCO: Large Inflows Detected at ETF
ETFChannel.com - Wed Jun 11, 9:53AM CDT
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the iShares MSCI Emerging Markets ETF where we have detected an approximate $295.9 million dollar inflow -- that's a 0.8%...

'Fast Money' Recap: Another Week, Another Record Close
at The Street - Sat Jun 07, 4:00AM CDT
The trading panel discussed whether value stocks can still be found in this market.

iShares MSCI Emerging Markets Index Fund/United States Rises 1.05% on Heavy Volume: Watch For Potential Pullback
Comtex SmarTrend(R) - Thu Jun 05, 3:39PM CDT
iShares MSCI Emerging Markets Index Fund/United States (NYSE:EEM) traded in a range yesterday that spanned from a low of $42.90 to a high of $43.20. Yesterday, the shares gained 1.1%, which took the trading range above the 3-day high of $43.04 on volume of 40.3 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Webull Faces Class Action Suit: Key Deadlines Loom

Updated Category News Views 236

The Clock is Ticking for Webull Investors If anyone's got a Webull stake, listen up! You’ve got a deadline that's staring you in the face: December 7, 2026. This is when you need to throw your hat in the ring to be a lead plaintiff in the Webull Corporation class action. We're talking securities fraud, folks, with allegations flying that would make your head spin....

Continue Reading
D-Wave's Legal Trouble: Securities Fraud Suit Looms

Updated Category News Views 294

A Looming Legal Storm for D-Wave Investors Call it another day, another legal tangle in the investing world. This time, it's D-Wave Quantum Inc. (NASDAQ: QBTS) on the receiving end of a securities fraud class action lawsuit. Yeah, those fancy quantum computers they're pushing didn't predict this one coming. The legal arena is getting ready for a bout, and if you've got...

Continue Reading
TCL's Display Future: AI Meets Screens at DTC 2026

Updated Category News Views 637

Exploring New Horizons in Display Technology There's something brewing in Wuhan: a conference that’s shaping up like a tech enthusiast’s dream. This year, it's all about the symbiosis of cutting-edge tech and dazzling visuals as TCL CSOT gears up to unveil advancements at the Global Display Tech-Ecosystem Conference (DTC) 2026. If you're wondering whether this event...

Continue Reading
Cleaner Air in Bedroom May Stabilize Blood Sugar Levels

Updated Category News Views 296

Imagine a world where simply sleeping in cleaner air could affect your blood sugar. Seems far-fetched, I know. But that's where we're at with this new study out of NYU Langone Health. They're talking about using plain ol' portable air filters to help steady blood sugar levels for folks dealing with prediabetes. Turns out a cleaner bedroom might just hold the key to taming...

Continue Reading
Fibocom LTE Modules Test Drive Satellite Connectivity

Updated Category News Views 153

Boosting IoT with Satellite Connectivity Here's a good one for folks watching the edge of wireless innovation. Fibocom's LTE Cat.1 bis modules, the LE270-EU and LE271-GL, just stretched their legs in New Zealand, connecting seamlessly with SpaceX's Direct to Cell (DTC) satellite system. No fancy hardware swaps, just standard firmware strutting its stuff across satellite...

Continue Reading
ASTS Faces Class Action; Investors Beware of Pitfalls

Updated Category News Views 281

Securities Fraud Allegations Hit AST SpaceMobile Days like this remind me why we keep our eyes peeled in the stock game—AST SpaceMobile (NASDAQ: ASTS) is tangled in a web of legal drama, and it's something you can't brush off with a shrug. Class action lawsuits for securities fraud? That's like finding out the foundation's shaky beneath a skyscraper. If you've got skin...

Continue Reading
Allergan Aesthetics Study Shows Rising Patient Satisfaction

Updated Category News Views 344

Enhanced Patient Satisfaction with Aesthetic Treatments Dive into the latest studies from Allergan Aesthetics—AbbVie's heavyweight in the beauty battleground. If you've got an ounce of optimism left in this market, their recent findings might just lift your spirits. Phase 4 studies, namely HARMONY IN DIVERSITY and HALO, are showing highly positive results among patients...

Continue Reading
Amplifon Data Breach Spurs Legal Scrutiny for Millions

Updated Category News Views 385

Data Breach Fallout: Amplifon Under Fire When a big player like Amplifon gets hit with a data breach, it's like a wake-up call across the board. This one’s no small spill—over 1.3 million folks left wondering whether their personal information is fluttering around cyberspace for all who dare to peek. If you’ve missed the memo, Edelson Lechtzin LLP, the savvy cats in...

Continue Reading
JNJ's Dual-Antigen Therapy Shows Promise in Prostate Cancer

Updated Category News Views 254

Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...

Continue Reading
Novo's Semaglutide Shows Promise in MASH Study

Updated Category News Views 337

Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...

Continue Reading
"blog__more"> More News Articles